CoChat

Genetic Modulation of GABA Levels in the Anterior Cingulate Cortex by GAD1 and COMT

Open access
Marenco, Stefano, Savostyanova, Antonina A, van der Veen, Jan Willem, Geramita, Matthew, Stern, Alexa, Barnett, Alan S, Kolachana, Bhaskar, Radulescu, Eugenia, Zhang, Fengyu, Callicott, Joseph H, Straub, Richard E, Shen, Jun, Weinberger, Daniel R · 2010 · Neuropsychopharmacology
Cited by 73

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

γ-Aminobutyric acid (GABA)-ergic transmission is critical for normal cortical function and is likely abnormal in a variety of neuropsychiatric disorders. We tested the in vivo effects of variations in two genes implicated in GABA function on GABA concentrations in prefrontal cortex of living subjects: glutamic acid decarboxylase 1 (GAD1), which encodes GAD67, and catechol-o-methyltransferase (COMT), which regulates synaptic dopamine in the cortex. We studied six single nucleotide polymorphisms (SNPs) in GAD1 previously associated with risk for schizophrenia or cognitive dysfunction and the val158met polymorphism in COMT in 116 healthy volunteers using proton magnetic resonance spectroscopy. Two of the GAD1 SNPs (rs1978340 (p=0.005) and rs769390 (p=0.004)) showed effects on GABA levels as did COMT val158met (p=0.04). We then tested three SNPs in GAD1 (rs1978340, rs11542313, and rs769390) for interaction with COMT val158met based on previous clinical results. In this model, rs11542313 and COMT val158met showed significant main effects (p=0.001 and 0.003, respectively) and a trend toward a significant interaction (p=0.05). Interestingly, GAD1 risk alleles for schizophrenia were associated with higher GABA/Cre, and Val-Val homozygotes had high GABA/Cre levels when on a GAD1 risk genotype background (N=6). These results support the importance of genetic variation in GAD1 and COMT in regulating prefrontal cortical GABA function. The directionality of the effects, however, is inconsistent with earlier evidence of decreased GABA activity in schizophrenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2010.35

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 73

Metadata

Authors
Marenco, S., Savostyanova, A. A., van der Veen, J. W., Geramita, M., Stern, A., Barnett, A. S., Kolachana, B., Radulescu, E., Zhang, F., Callicott, J. H., Straub, R. E., Shen, J., & Weinberger, D. R.
Venue
Neuropsychopharmacology
Published
2010-03-31
Volume
35
Issue
8
Pages
1708-1717
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2019182935
Cited by
73
References
18
FWCI
2.93
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Modulation of GABA Levels in the Anterior Cingulate Cortex by GAD1 and COMT. https://app.cochat.ai/papers/10.1038/npp.2010.35
The paper
Marenco, S., Savostyanova, A. A., van der Veen, J. W., Geramita, M., Stern, A., Barnett, A. S., Kolachana, B., Radulescu, E., Zhang, F., Callicott, J. H., Straub, R. E., Shen, J., & Weinberger, D. R. (2010). Genetic Modulation of GABA Levels in the Anterior Cingulate Cortex by GAD1 and COMT. Neuropsychopharmacology. https://doi.org/10.1038/npp.2010.35

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.